Form 8-K - Current report:
SEC Accession No. 0001104659-23-024510
Filing Date
2023-02-23
Accepted
2023-02-23 07:05:27
Documents
15
Period of Report
2023-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237635d1_8k.htm   iXBRL 8-K 34809
2 EXHIBIT 10.1 tm237635d1_ex10-1.htm EX-10.1 61675
3 EXHIBIT 99.1 tm237635d1_ex99-1.htm EX-99.1 10284
7 GRAPHIC tm237635d1_ex99-1rimg015.jpg GRAPHIC 2014
  Complete submission text file 0001104659-23-024510.txt   304513

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA asrt-20230223.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20230223_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20230223_pre.xml EX-101.PRE 22599
9 EXTRACTED XBRL INSTANCE DOCUMENT tm237635d1_8k_htm.xml XML 3606
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 23655890
SIC: 2834 Pharmaceutical Preparations